RPT-DEALTALK-Trump's corporate tax holiday could spur pharma M&A

Dec 6 (Reuters) - U.S. President-elect Donald Trump's plan to incentivize U.S. companies to repatriate their swelling overseas cash piles could spur a new wave of dealmaking in a pharmaceutical industry seeking to buy its way into growth.